tirzepatide and protein intake on Tirzepatide: Clinical Guidance & Biomarkers – PlexusDx 🧬 GLP-1 DOs & DON'Ts

This weight regain occurs because the medications appetite suppression effects wear off, hunger and cravings return, and without ongoing treatment, the physiological factors that contributed to weight gain resume

Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis

There are risks associated with scaling up manufacturing to commercial volumes including, among others, cost overruns, technical problems with process scale-up, process reproducibility, stability issues, and lot consistency

For many higher risk patients, the future monitoring model probably needs to combine body composition with functional and clinical context, not interpret lean mass changes in isolation